(S)-1-(4-Aminoxyacetamidobenzyl)ethylenediaminetetraacetic Acid(CAS: 1217704-71-6)

This compound requires adherence to the GHS classification, which categorizes it based on its potential health and environmental hazards. For production and import, it must comply with the REACH regulations in the European Union, ensuring that it does not pose a risk to human health or the environment. Additionally, the FDA and EPA have specific requirements for handling and reporting on this compound in the United States, focusing on its safe use in medical applications.

There are alternative chelating agents that can be used as substitutes, such as EDTA and DTPA, which have similar functionalities. However, the specific isomer (S)-1-(4-Aminoxyacetamidobenzyl)EDTA offers unique chelating properties, making it less readily replaceable. Synthesis alternatives often depend on the specific application and availability of reagents.

The market and research trends for this compound are growing, particularly in medical applications such as imaging agents and drug delivery systems. Recent studies are focusing on its potential in cancer diagnostics and targeted therapies. The trend indicates increasing demand, driven by advancements in medical technology and the need for more precise and effective treatment options.

Waste containing this compound should be collected in appropriate containers and handled according to local hazardous waste regulations. Professional incineration or chemical treatment is recommended for disposal to ensure that the waste is properly neutralized and that environmental contamination is minimized. Always follow local guidelines and consult with environmental protection agencies for specific disposal procedures.